Immunofluorescence
Immunostaining were performed as previously reported (1) . Samples were incubated overnight with SNAT2 primary antibodies and then incubated with fluorescently conjugated donkey secondary antibodies and DAPI for 1 h at 37°C followed by a further three 10-min washes in PBST. All samples were imaged on a Zeiss LSM 780 confocal microscope. Magnification images were obtained using the x40 objective (1.4NA, Oil DIC, Plan-APOCHROMAT). Image J software was used to quantify SNAT2 intensity as previously described (2) .
Determination of glutamine consumption
Cells (1×104/well) in a 24 well plate were cultured for 24 hours in medium without phenol red, the medium was collected, and cells were lysed with RIPA buffer (Sigma-Aldrich). Concentrations of glutamine in the medium and in the cell lysate were determined with the Glutamine Detection Assay Kit (Abcam, ab197011). A standard curve was determined for each experiment to calculate the concentration of glutamine in samples as per manufacture guideline. Glutamine levels were calculated and normalized to total protein levels. The glutamine level of normal culture medium was also measured, and the glutamine consumption was calculated as (glutamine in normal medium -glutamine in the medium after culturing cells) and normalized to protein level.
Mitochondrial Permeability Potential
Cells were stained with the cationic dye JC-1 (Thermofisher). At low membrane potentials, JC-1 exists as a monomer and produces a green fluorescence (emission at ≈527 nm) while at high 
Generation of SNAT2 and HIF-1α overexpressing MCF7
Stable MCF7 control or overexpressing the full-length SNAT2 cell lines were generated using viral infections. Briefly, 30 µg of empty vector-containing pLenti6.2-V5 plasmid or full-length SNAT2
cDNA-containing pLenti6.2-V5 plasmid with 15-µg pPAX2 and 5µg of pMDG.2 (Addgene) were transfected into HEK293t packaging cell line using the CaCl2 method. The viral supernatant was recovered and the transduced cells were generated by infection at 5 MOI (multiplicity of infectious units) and selected with 1 µg/mL of Puromycin for 1 week. SNAT2 expression was confirmed by
Western blot. The generation of MCF7 HIF-1α overexpressing cells was previously reported (3).
Immunohistochemistry
Immunohistochemistry was carried out as previously described (4) . The following primary antibodies were used at overnight incubation: anti-mouse CD31/PECAM (1:100, Clone ER-MP12, ThermoFisher) mouse anti-CA9 (M75, Absolute antibody, 1:100), rabbit anti-SNAT2 (BMP081, MBL International, 1:100) and Pimonidazole (Hypoxyprobe-1; Chemicon International, 1:100). A standard hematoxylin and eosin protocol was followed to assess the amount of necrosis on xenografts. Slides were incubated with secondary antibody (Dako) for 45 minutes and washed in PBS. 3,3′-Diaminobenzidine (DAB, Dako) was applied to the sections for 7 minutes. The slides were counterstained by immersing in hematoxylin solution (Sigma-Aldrich) and mounted with Aquamount (VWR). Secondary-only control staining was performed routinely. Necrosis was quantified histologically on hematoxylin-stained sections as previously described (4). Expression of CA9 and necrosis was quantified on whole sections by using ImageJ software (US National
Institutes of Health, Bethesda, MD, USA). Expression of CD31 was quantified by using 15 random fields of slides at × 100 magnification.
Immunoblotting
Protein concentrations were quantified using a BCA protein assay kit (Thermo Fisher Scientific, Cramlington, UK). Samples containing 30µg of protein were in Laemmli buffer and separated using 8-12% pre-cast SDS-PAGE gels (Bio-Rad, USA). Proteins were transferred to PVDF membranes (Sigma, Steinheim, Germany) using ECL plus reagent (GE Healthcare, UK). Image J software was used to quantify bands intensities after β-actin normalization.
Seahorse XF-24 metabolic flux analysis.
Oxygen consumption rates and extracellular acidification rate were measured at 37°C using an XF24 extracellular analyzer (Seahorse Bioscience). MCF7 were plated in 24-well plates for 24 h (25,000 cells per well) in DMEM 5mM glucose, 4mM glutamine with or without SNAT2
knockdown. 24 hours before the experiments fulvestrant (ICI 182,780, 10µM) was administered. 
Generation of MCF7 cells lacking functional HIF-1α using CRISPR/Cas9
CRISPR-Cas9 expression constructs were designed and cloned into pSpCas9(BB)-2A-Puro as previously described (5) To verify the sequence of mutated HIF-1α alleles, genomic DNA from HIF-1α-mutant MCF7 cells was extracted using the NucleoSpin Blood kit (Macherey-Nagel), according to the manufacturer's instructions. Exon 2 of the HIF-1α gene, which had been targeted using CRISPR/Cas9, was amplified (forward primer: TTCCATCTCGTGTTTTTCTTGTTGT, reverse primer:
CAAAACATTGCGACCACCTTCT) and PCR products were resolved on a 2% agarose gel. Bands around the expected size (317 bp) were purified and ligated into the pCR4Blunt-TOPO vector using the Zero Blunt TOPO PCR Kit for Sequencing (Thermo Fisher Scientific). Ligation products were transformed into One Shot TOP10 Chemically Competent E. coli cells (Thermo Fisher Scientific).
E. coli cells were plated on LB plates containing kanamycin with X-gal (20 µl per plate, 8% w/v in dimethylformamide) and plasmid DNA was amplified and sequenced from 10 blue E. coli colonies (M13 forward primer: TGTAAAACGACGGCCAGT). Error bars, SD. ***, P < 0.001; **, P < 0.01; *, P < 0.05 for all the experiments. 
